If approved, MCO-010 would be the first treatment to restore vision in legally blind RP patients without needing genetic ...

San Diego, USA-based Neurocrine Biosciences on Monday reported new positive data from the Phase III CAHtalyst Adult study of ...

US biotech major Vertex Pharmaceuticals (Nasdaq: VRTX) has reached a wide-ranging reimbursement deal with NHS England for ...

USA-based Uniquity Bio has appointed industry veteran Will Kane as its president and chief executive. The clinical-stage drug ...

Indian drugmaker Sun Pharmaceutical Industries together with its subsidiaries announced that further to its intimation dated ...

A quiet shift with potentially big implications for cancer drug access is underway in the UK. In June, the country’s health ...

Germany’s Bayer has announced that the US Food and Drug Administration (FDA) has approved Kerendia (finerenone) to treat ...

China’s vaccine landscape is shifting after local biotech Xiamen Innovax Biotech unveiled the country’s first domestically ...

South Korean biotech Illimis Therapeutics has raised 58 billion won ($42 million) in a series B round to advance its GAIA ...

The Amsterdam District Court has delivered a ruling in the lawsuit brought by Farma ter Verantwoording (FtV) — The ...

Japan’s largest pharma company Taked today announced that all primary and secondary endpoints were met in two Phase III ...

The Flamma Group has celebrated the grand opening of its new cGMP plant in Dalian, China. A contract development and ...